Glycan Therapeutics LLC STTR Phase I Award, August 2017

A STTR Phase I contract was awarded to Glycan Therapeutics in August, 2017 for $224,698.0 USD from the U.S. Department of Health & Human Services.

Is a

SBIR/STTR Award Recipient

Government Agency

Award Type

STTR0

Contract Number (US Government)

1R41HL139187-010

Award Phase

Phase I0

Award Amount (USD)

224,6980

Date Awarded

August 1, 2017

End Date

July 31, 2018

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like Glycan Therapeutics LLC STTR Phase I Award, August 2017

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.